MBOT Microbot Medical Inc.

Fundamentals / CIK 0000883975 / USD

Microbot Medical Inc. reported $68.21M in total assets and a net loss of $18.60M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MBOT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$12.31MFY 2016 Net Income: -$9.66M2016FY 2017 Net Income: -$7.59M2017FY 2018 Net Income: -$7.26M2018FY 2019 Net Income: -$7.25M2019FY 2020 Net Income: -$9.17M2020FY 2021 Net Income: -$11.31M2021FY 2022 Net Income: -$13.17M2022FY 2023 Net Income: -$10.74M2023FY 2024 Net Income: -$11.44M2024FY 2025 Net Income: -$13.14M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $6.28M $6.63M $5.72M $7.74M $6.15M $3.40M $3.05M $2.52M $1.10M -$901K
Selling, General & Admin $8.46M $5.00M -- -- -- -- -- -- -- --
Operating Income -$14.74M -$11.62M -$9.86M -$13.28M -$11.36M -$9.09M -$7.24M -$7.24M $5.27M -$9.63M
EBITDA -$14.70M -$11.53M -$9.75M -$13.18M -$11.28M -$9.02M -$7.16M -$7.19M $5.29M -$9.62M
Interest Expense -- -- -- -- -- -- -- -- $237K $333K
Income Tax Expense -- -- -- -- -- $0 $0 -- -- --
Net Income -$13.14M -$11.44M -$10.74M -$13.17M -$11.31M -$9.17M -$7.25M -$7.26M -$7.59M -$9.66M
Basic EPS -$0.29 -$0.73 -$1.05 -$1.81 -$1.59 -$1.29 -$1.70 -$2.41 -$2.76 $0.40
Diluted EPS -$0.29 -$0.73 -$1.05 -$1.81 -$1.59 -$1.29 -$1.70 -$2.41 -$2.76 $0.40
Basic Shares Outstanding 45.8M 15.6M 10.2M 7.3M 7.1M 7.1M 4.3M 2.9M 2.2M 14.3M
Diluted Shares Outstanding 45.8M 15.6M 10.2M 7.3M 7.1M 7.1M 4.3M 2.9M 2.2M 14.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $72K $241K $105K -- -- -- -- --
Cost of Revenue $1.09M $884K $103K -- -- -- -- --
Gross Profit -$1.02M -$643K $2.0K -- -- -- -- --
Research & Development $1.63M $1.86M $1.29M $1.54M $1.17M $2.11M $1.46M $1.98M
Selling, General & Admin $1.84M $3.68M $3.03M $3.13M $2.16M $1.61M $1.56M --
Operating Income -$6.49M -$6.19M -$4.32M -$4.14M -$3.86M -$3.72M -$3.02M -$3.43M
EBITDA -$6.47M -$6.17M -$4.31M -$4.13M -$3.85M -$3.71M -$3.01M -$3.40M
Net Income -$5.84M -$5.63M -$3.67M -$3.46M -$3.58M -$3.50M -$2.60M -$3.39M
Basic EPS -$0.09 -$0.08 -$0.05 -- -$0.07 -$0.10 -$0.08 --
Diluted EPS -$0.09 -$0.08 -$0.05 -- -$0.07 -$0.10 -$0.08 --
Basic Shares Outstanding 67.2M 67.2M 67.2M -- 48.1M 36.5M 31.1M --
Diluted Shares Outstanding 67.2M 67.2M 67.2M -- 48.1M 36.5M 31.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.91M $3.11M $2.47M $2.44M $13.49M $19.65M $28.77M $5.24M $10.79M $2.71M
Short-Term Investments $74.68M $2.36M $3.92M $5.76M $2.00M $5.00M $2.52M -- -- --
Cash & Short-Term Investments $78.59M $5.47M $6.38M $8.20M $15.49M $24.65M $31.29M $5.24M $10.79M $2.71M
Inventory $584K -- -- -- -- -- -- -- -- --
Other Current Assets -- -- $1.33M -- $300K $521K $286K $568K $116K $606K
Total Current Assets $79.82M $5.82M $7.92M $8.81M $15.88M $25.25M $35.94M $5.83M $10.93M $3.31M
Property, Plant & Equipment, Net $93K $80K $146K $221K $244K $251K $228K $259K $90K $53K
Total Non-Current Assets $1.72M $212K $406K $723K $888K $1.03M $1.19M $259K $90K $53K
Total Assets $81.54M $6.03M $8.33M $9.54M $16.77M $26.28M $37.13M $6.09M $11.02M $3.37M
Accounts Payable $511K $165K $357K $116K $279K $275K $284K $630K $78K $512K
Other Current Liabilities $5.0K $5.0K $79K -- -- -- $608K $468K $330K $145K
Total Current Liabilities $3.42M $2.46M $3.79M $2.07M $1.98M $1.34M $4.83M $4.76M $528K $783K
Total Non-Current Liabilities $569K $41K $40K $179K $402K $626K $760K $8.0K $28K $389K
Total Liabilities $3.99M $2.50M $3.83M $2.25M $2.39M $1.97M $5.59M $4.76M $556K $1.17M
Total Debt (incl. Leases) $865K $111K $231K $462K $680K $813K $903K -- -- --
Common Stock $672K $195K $118K $80K $72K $72K $72K $31K $27K $266K
Retained Earnings -$104.1M -$90.94M -$79.50M -$68.76M -$55.59M -$44.28M -$35.11M -$27.86M -$20.62M -$13.04M
Total Stockholders' Equity $77.55M $3.53M $4.50M $7.29M $14.38M $24.31M $31.54M $1.33M $9.99M $1.70M
Total Equity $77.55M $3.53M $4.50M $7.29M $14.38M $24.31M $31.54M $1.33M $9.99M $1.70M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.29M $3.15M $3.66M $3.91M $6.70M $4.08M $3.22M $3.11M
Short-Term Investments $59.54M $64.22M $68.84M $74.68M $73.45M $28.59M $27.17M $2.36M
Cash & Short-Term Investments $61.83M $67.37M $72.50M $78.59M $80.16M $32.67M $30.39M $5.47M
Accounts Receivable, Net $90K $176K $105K -- -- -- -- --
Inventory $3.21M $2.91M $2.26M $584K -- -- -- --
Total Current Assets $66.87M $72.17M $76.53M $79.82M $80.78M $32.89M $30.66M $5.82M
Property, Plant & Equipment, Net $486K $316K $188K $93K $78K $75K $78K $80K
Total Non-Current Assets $1.34M $1.19M $1.54M $1.72M $975K $240K $236K $212K
Total Assets $68.21M $73.36M $78.07M $81.54M $81.76M $33.13M $30.89M $6.03M
Accounts Payable $857K $871K $1.08M $511K $509K $503K $186K $165K
Other Current Liabilities -- -- -- $5.0K -- -- -- $5.0K
Total Current Liabilities $4.26M $3.89M $3.39M $3.42M $2.93M $2.73M $1.89M $2.46M
Total Non-Current Liabilities $504K $550K $574K $569K $602K $47K $48K $41K
Total Liabilities $4.76M $4.44M $3.96M $3.99M $3.54M $2.77M $1.94M $2.50M
Total Debt (incl. Leases) $838K $876K $898K $865K $899K $149K $138K $111K
Common Stock $672K $672K $672K $672K $659K $380K $348K $195K
Retained Earnings -$119.2M -$113.4M -$107.8M -$104.1M -$100.6M -$97.05M -$93.55M -$90.94M
Total Stockholders' Equity $63.45M $68.93M $74.11M $77.55M $78.22M $30.36M $28.95M $3.53M
Total Equity $63.45M $68.93M $74.11M $77.55M $78.22M $30.36M $28.95M $3.53M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$13.14M -$11.44M -$10.74M -$13.17M -$11.31M -$9.17M $7.25M $7.26M $7.59M $9.66M
Depreciation & Amortization $47K $91K $106K $102K $76K $68K $84K $54K $21K $10K
Stock-Based Compensation $1.06M $1.35M $1.39M $1.75M $1.39M $1.94M $1.10M $1.40M $479K $676K
Change in Inventory -$584K -- -- -- -- -- -- -- -- --
Operating Cash Flow -$13.05M -$8.83M -$8.53M -$11.55M -$9.35M -$7.25M -$6.45M -$5.31M -$4.86M -$786K
Capital Expenditure -$60K -$25K -$33K -$84K -$69K -$91K -$216K -$223K -$58K -$25K
Free Cash Flow -$13.11M -$8.85M -$8.57M -$11.63M -$9.42M -$7.34M -$6.67M -$5.53M -$4.91M -$811K
Purchases of Investments -- -- -$10.06M -$3.75M -- -$5.00M -$2.50M -- -- --
Sales & Maturities of Investments -- -- -- -- $270K -- -- -- -- --
Investing Cash Flow -$72.38M $1.54M $1.97M -$3.84M $3.20M -$2.77M -$2.45M -$223K -$58K -$25K
Common Stock Issued $86.24M $7.94M $6.56M $4.32M -- -- $36.77M -- $12.70M --
Financing Cash Flow $86.24M $7.94M $6.56M $4.32M -- -$3.38M $36.77M -$18K $13.02M $3.08M
Net Change in Cash $810K $646K -$2.0K -$11.06M -$6.15M -$13.39M $27.87M -$5.55M $8.11M $2.27M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.84M -$5.63M -$3.67M -$3.46M -$3.58M -$3.50M -$2.60M -$3.39M
Depreciation & Amortization $28K $15K $12K $10K $10K $12K $15K $26K
Stock-Based Compensation $362K $433K $222K $236K $328K $237K $256K $282K
Change in Receivables $86K -$71K -$105K -- -- -- -- --
Change in Inventory -$306K -$650K -$1.67M -- -- -- -- --
Operating Cash Flow -$5.41M -$4.99M -$5.05M -$3.76M -$3.84M -$2.57M -$2.87M -$1.69M
Capital Expenditure -$115K -$142K -$108K -$25K -$13K -$9.0K -$13K -$7.0K
Free Cash Flow -$5.52M -$5.13M -$5.16M -$3.78M -$3.85M -$2.58M -$2.89M -$1.70M
Purchases of Investments -$582K -$629K -$441K -- -$48.00M -$3.80M -$28.12M --
Investing Cash Flow $4.55M $4.47M $5.00M -$1.53M -$44.71M -$1.31M -$24.83M $1.50M
Common Stock Issued -- -- -- $2.51M $51.17M $4.75M $27.81M $2.83M
Financing Cash Flow -- -- -- $2.51M $51.18M $4.75M $27.81M $2.83M
Net Change in Cash -$861K -$502K -$56K -$2.79M $2.62M $870K $102K $2.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -16.9% -324.2% -238.6% -180.7% -78.7% -37.7% -23.0% -545.9% -76.0% -569.8%
Return on Assets (ROA) -16.1% -189.7% -129.0% -138.1% -67.5% -34.9% -19.5% -119.2% -68.9% -286.9%
Current Ratio 23.33x 2.37x 2.09x 4.26x 8.00x 18.78x 7.45x 1.23x 20.70x 4.23x
Quick Ratio 23.16x 2.22x 1.69x 3.96x 7.81x 18.33x 6.48x 1.10x 20.43x 3.46x
Debt to Equity 0.01x 0.03x 0.05x 0.06x 0.05x 0.03x 0.03x -- -- --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -237.5% -- -1153.0%
EPS Growth (YoY) -- -- -- -- -- -- -- -- -790.0% +900.0%

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -29.3% -23.7% -19.2% -16.9% -16.7% -41.9% -40.3% -324.2%
Return on Assets (ROA) -27.3% -22.3% -18.2% -16.1% -16.0% -38.4% -37.8% -189.7%
Current Ratio 15.70x 18.56x 22.59x 23.33x 27.53x 12.06x 16.19x 2.37x
Quick Ratio 14.94x 17.82x 21.93x 23.16x 27.32x 11.98x 16.05x 2.22x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.00x 0.00x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0000883975) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal